http://www.sciencedaily.com/news/health_medicine/herpes/ Herpes news. Read the latest research on the herpes virus, including new treatment options. en-us Sat, 26 May 2012 13:05:01 EDT Sat, 26 May 2012 13:05:01 EDT 60 http://www.sciencedaily.com/images/logosmall.gif http://www.sciencedaily.com/news/health_medicine/herpes/ For more science articles, visit ScienceDaily. http://www.sciencedaily.com/releases/2012/05/120510122857.htm The movement of genetic materials, such as RNA and ribosomes, from the nucleus to the cytoplasm is a critical component in a cell's ability to make the proteins necessary for essential biological functions. Until now, it was believed the nuclear pore complex was the sole pathway between the cell nucleus and cytoplasm for these materials. New evidence reveals a novel budding mechanism, similar to the process used by some viruses, capable of exporting large ribonucleoprotein particles from the nucleus to the cytoplasm. Thu, 10 May 2012 12:28:28 EDT http://www.sciencedaily.com/releases/2012/05/120510122857.htm http://www.sciencedaily.com/releases/2012/04/120423104949.htm The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults. Mon, 23 Apr 2012 10:49:49 EDT http://www.sciencedaily.com/releases/2012/04/120423104949.htm http://www.sciencedaily.com/releases/2012/04/120411084040.htm Up until now the causes of the development of chronic lymphatic leukemia, the most common form of cancer of the blood in Europe, have been unknown. At present a cure is not possible. Medical researchers have now however discovered a lead on the origin of this disease. Wed, 11 Apr 2012 08:40:40 EDT http://www.sciencedaily.com/releases/2012/04/120411084040.htm http://www.sciencedaily.com/releases/2012/03/120326133554.htm New biological research reveals how an invading virus hijacks a cell's workings by imitating a signaling marker to defeat the body's defenses. By manipulating cell signals, the virus destroys a defensive protein designed to inhibit it. This finding, from studies in human cell cultures, may represent a broader targeting strategy used by other viruses, and may lay the scientific groundwork for developing more effective treatments for infectious diseases. Mon, 26 Mar 2012 13:35:35 EDT http://www.sciencedaily.com/releases/2012/03/120326133554.htm http://www.sciencedaily.com/releases/2012/01/120104174816.htm New research points investigators toward finding a genital herpes vaccine that works on both viruses that cause disease. Wed, 04 Jan 2012 17:48:48 EST http://www.sciencedaily.com/releases/2012/01/120104174816.htm http://www.sciencedaily.com/releases/2011/11/111130100526.htm Researchers have identified the first gene associated with frequent herpes-related cold sores. Wed, 30 Nov 2011 10:05:05 EST http://www.sciencedaily.com/releases/2011/11/111130100526.htm http://www.sciencedaily.com/releases/2011/10/111028082704.htm Researchers have identified a human chromosome containing a specific gene associated with susceptibility to herpes simplex labialis, the common cold sore. The study looks at how several genes may affect the severity of symptoms and frequency of this common infection. The findings, if confirmed, could have implications for the development of new drugs to treat outbreaks. Fri, 28 Oct 2011 08:27:27 EDT http://www.sciencedaily.com/releases/2011/10/111028082704.htm http://www.sciencedaily.com/releases/2011/10/111017102557.htm Antiviral drugs used to target the herpes virus could be effective at slowing the progression of Alzheimer's disease, a new study shows. Mon, 17 Oct 2011 10:25:25 EDT http://www.sciencedaily.com/releases/2011/10/111017102557.htm http://www.sciencedaily.com/releases/2011/08/110819131510.htm Danish researchers have become the first in the world to regulate a special receptor or bio-antenna that plays a vital part when the Epstein Barr herpes virus infects us and when this infection appears to be mutating into cancer of the immune system. Using a biochemical blueprint and a tiny bio-molecule researchers have succeeded in blocking the receptor concerned. This will make it possible to adjust and regulate the memory cells of the immune system. Fri, 19 Aug 2011 13:15:15 EDT http://www.sciencedaily.com/releases/2011/08/110819131510.htm http://www.sciencedaily.com/releases/2011/08/110815162233.htm An early phase clinical trial has shown that a form of gene therapy is safe even when combined with radiation therapy for treating brain tumors such as glioblastoma multiforme, the most common and dangerous form of brain cancer. The novel treatment uses an adenovirus vector that is taken up by cancer cells where it activates a drug that kills the cells. Mon, 15 Aug 2011 16:22:22 EDT http://www.sciencedaily.com/releases/2011/08/110815162233.htm http://www.sciencedaily.com/releases/2011/06/110628163321.htm Researchers have discovered a naturally occurring disease in monkeys that is very much like multiple sclerosis in humans -- a discovery that could have a major impact on efforts to understand the cause of multiple sclerosis. Tue, 28 Jun 2011 16:33:33 EDT http://www.sciencedaily.com/releases/2011/06/110628163321.htm http://www.sciencedaily.com/releases/2011/06/110627095459.htm Herpes infections on the lips, in the eyes or on the nose are painful, long-lasting and unpleasant. A new 3D herpes infection model brings hope: active ingredients and new treatments can be reliably tested with this model. Animal tests could soon be a thing of the past. Mon, 27 Jun 2011 09:54:54 EDT http://www.sciencedaily.com/releases/2011/06/110627095459.htm http://www.sciencedaily.com/releases/2011/06/110608123006.htm Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings support a long-held view on how MS may develop. Wed, 08 Jun 2011 12:30:30 EDT http://www.sciencedaily.com/releases/2011/06/110608123006.htm http://www.sciencedaily.com/releases/2011/05/110517091634.htm While there is no cause known for multiple sclerosis, patients with MS seem to have genetic vulnerability to certain environmental factors that could trigger this condition, such as the Epstein-Barr virus. Scientists have now found a link between the Epstein-Barr virus --- which belongs to the herpes viruses family --- and the development of this condition. Tue, 17 May 2011 09:16:16 EDT http://www.sciencedaily.com/releases/2011/05/110517091634.htm http://www.sciencedaily.com/releases/2011/05/110511193250.htm Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a new study. Wed, 11 May 2011 19:32:32 EDT http://www.sciencedaily.com/releases/2011/05/110511193250.htm http://www.sciencedaily.com/releases/2011/05/110511170934.htm Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence. The novel technology has the potential to vastly improve cancer diagnosis by allowing the disease to be caught at much earlier stages and to monitor the effectiveness of therapy. Wed, 11 May 2011 17:09:09 EDT http://www.sciencedaily.com/releases/2011/05/110511170934.htm http://www.sciencedaily.com/releases/2011/04/110415083142.htm Strains of genital herpes in Africa are far more virulent than those in the United States, researchers report -- a striking insight into a common disease with important implications for preventing HIV transmission in a region staggered by the HIV/AIDS epidemic. Fri, 15 Apr 2011 08:31:31 EDT http://www.sciencedaily.com/releases/2011/04/110415083142.htm http://www.sciencedaily.com/releases/2011/04/110414160942.htm A folk remedy may be an effective treatment for the sexually transmitted disease herpes according to new research. Thu, 14 Apr 2011 16:09:09 EDT http://www.sciencedaily.com/releases/2011/04/110414160942.htm http://www.sciencedaily.com/releases/2011/04/110412101324.htm Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations) episodes, suggesting a high risk of transmission from persons with unrecognized HSV-2 infection, according to a new study. Tue, 12 Apr 2011 10:13:13 EDT http://www.sciencedaily.com/releases/2011/04/110412101324.htm http://www.sciencedaily.com/releases/2011/04/110411163914.htm A study of patients attending sexual health clinics in Gothenburg, Sweden found that just four out of ten patients with genital herpes actually knew that they had the disorder. However, a third of those who did not realize that they had been infected reported typical symptoms at a follow-up visit, reveals new research. Mon, 11 Apr 2011 16:39:39 EDT http://www.sciencedaily.com/releases/2011/04/110411163914.htm http://www.sciencedaily.com/releases/2011/04/110404122203.htm New research using a new technique to observe herpes simplex virus type 1 infections inside cells, finds that re-activation and growth of HSV1 infections contribute to cognitive decline associated with Alzheimer's disease. Mon, 04 Apr 2011 12:22:22 EDT http://www.sciencedaily.com/releases/2011/04/110404122203.htm http://www.sciencedaily.com/releases/2011/02/110222121903.htm Patients with chronic obstructive pulmonary disease (COPD) are at greater risk of shingles compared with the general population, according to a new study. The risk is greatest for patients taking oral steroids to treat COPD. Tue, 22 Feb 2011 12:19:19 EST http://www.sciencedaily.com/releases/2011/02/110222121903.htm http://www.sciencedaily.com/releases/2011/02/110207122009.htm A five-week old infant most likely contracted a vaccine strain of yellow fever virus through breastfeeding, according to a case report from Canada. Mon, 07 Feb 2011 12:20:20 EST http://www.sciencedaily.com/releases/2011/02/110207122009.htm http://www.sciencedaily.com/releases/2011/02/110205140049.htm Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak. Sat, 05 Feb 2011 14:00:00 EST http://www.sciencedaily.com/releases/2011/02/110205140049.htm http://www.sciencedaily.com/releases/2011/02/110201122536.htm For decades, medical wisdom about shingles has been that it's a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a new study, recurrences of shingles may be significantly more common than doctors have suspected. Tue, 01 Feb 2011 12:25:25 EST http://www.sciencedaily.com/releases/2011/02/110201122536.htm http://www.sciencedaily.com/releases/2011/01/110111165006.htm Vaccination for herpes zoster, a painful rash commonly known as shingles, among a large group of older adults was associated with a reduced risk of this condition, regardless of age, race or the presence of chronic diseases, according to a new study. Tue, 11 Jan 2011 16:50:50 EST http://www.sciencedaily.com/releases/2011/01/110111165006.htm http://www.sciencedaily.com/releases/2011/01/110106192027.htm For the first time, researchers have developed a 3-D picture of a herpes virus protein interacting with a key part of the human cellular machinery, enhancing our understanding of how it hijacks human cells to spread infection and opening up new possibilities for stepping in to prevent or treat infection. This discovery uncovers one of the many tactical maneuvers employed by the virus. Thu, 06 Jan 2011 19:20:20 EST http://www.sciencedaily.com/releases/2011/01/110106192027.htm http://www.sciencedaily.com/releases/2010/11/101116161248.htm A cellular protein called BST-2 had already been known to interfere with the spread of human immunodeficiency virus type 1 (HIV-1), by inhibiting the release of its progeny particles from infected cells. Now scientists show that in addition, each progeny virion's ability to cause infection is severely impaired. Tue, 16 Nov 2010 16:12:12 EST http://www.sciencedaily.com/releases/2010/11/101116161248.htm http://www.sciencedaily.com/releases/2010/10/101004130017.htm Acute herpes zoster, or shingles, interferes with all health areas for people with the condition, including sleep, enjoyment of life and general activities, according to a new study. Mon, 04 Oct 2010 13:00:00 EDT http://www.sciencedaily.com/releases/2010/10/101004130017.htm http://www.sciencedaily.com/releases/2010/09/100930101549.htm An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested in the recently concluded clinical study known as the Herpevac Trial for Women. Thu, 30 Sep 2010 10:15:15 EDT http://www.sciencedaily.com/releases/2010/09/100930101549.htm http://www.sciencedaily.com/releases/2010/09/100923081859.htm Scientists have shown that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus. This study is the first step towards the development of a drug against the entire herpesvirus family. Thu, 23 Sep 2010 08:18:18 EDT http://www.sciencedaily.com/releases/2010/09/100923081859.htm http://www.sciencedaily.com/releases/2010/09/100913162514.htm Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according a new report. Mon, 13 Sep 2010 16:25:25 EDT http://www.sciencedaily.com/releases/2010/09/100913162514.htm http://www.sciencedaily.com/releases/2010/08/100824161440.htm An analysis of data from Denmark finds no associated increased risk of major birth defects for mothers who were exposed during the first trimester of pregnancy to the antiviral drugs acyclovir, valacyclovir and famciclovir, often used to treat herpes simplex and herpes zoster infections, according to a new study. Tue, 24 Aug 2010 16:14:14 EDT http://www.sciencedaily.com/releases/2010/08/100824161440.htm http://www.sciencedaily.com/releases/2010/07/100719162649.htm Scientists have developed a new way to target viruses which could increase the effectiveness of antiviral drugs. Instead of attacking the virus itself, the method developed at the University of Edinburgh alters the conditions which viruses need to survive and multiply. Mon, 19 Jul 2010 16:26:26 EDT http://www.sciencedaily.com/releases/2010/07/100719162649.htm http://www.sciencedaily.com/releases/2010/07/100719142444.htm Researchers have achieved an important scientific breakthrough in the fight against HIV and genital herpes with a vaginal gel that significantly reduces a woman's risk of being infected with these viruses, according to a ground-breaking safety and effectiveness study of an antiretroviral microbicide gel study. Mon, 19 Jul 2010 14:24:24 EDT http://www.sciencedaily.com/releases/2010/07/100719142444.htm http://www.sciencedaily.com/releases/2010/07/100707102447.htm Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice -- still an elusive goal when treating humans with cancer, according to new research. The study results are even more significant because the oncolytic herpes virus was given to the mice systemically to attack tumors via the blood stream instead of being injected directly into tumors Wed, 07 Jul 2010 10:24:24 EDT http://www.sciencedaily.com/releases/2010/07/100707102447.htm http://www.sciencedaily.com/releases/2010/07/100706112603.htm New research reveals the unusual structure of a key protein complex that allows a herpes virus to invade cells. This close-up of the herpes virus's "cell-entry machinery" sheds light on how herpes viruses work and provides a promising new target for antiviral drugs. Tue, 06 Jul 2010 11:26:26 EDT http://www.sciencedaily.com/releases/2010/07/100706112603.htm http://www.sciencedaily.com/releases/2010/05/100528211200.htm Exposure to the common virus that causes cold sores may be partially responsible for shrinking regions of the brain and the loss of concentration skills, memory, coordinated movement and dexterity widely seen in patients with schizophrenia, according to research led by Johns Hopkins scientists. Fri, 28 May 2010 21:12:12 EDT http://www.sciencedaily.com/releases/2010/05/100528211200.htm http://www.sciencedaily.com/releases/2010/05/100506112609.htm Scientists have identified how the virus which causes Kaposi's sarcoma replicates and spreads -- opening a door to a possible new treatment for the disease. Thu, 06 May 2010 11:26:26 EDT http://www.sciencedaily.com/releases/2010/05/100506112609.htm http://www.sciencedaily.com/releases/2010/01/100122102435.htm Genital herpes caused by a reactivation of herpes simplex virus type 2 (HSV-2) is generally treated as a lesion in one specific area of the genital region. A new study, however, finds that the virus can frequently reactivate throughout the genital tract, an important new concept that could help guide both HSV-2 treatment and prevention. Fri, 22 Jan 2010 10:24:24 EST http://www.sciencedaily.com/releases/2010/01/100122102435.htm http://www.sciencedaily.com/releases/2010/01/100121141102.htm New video footage of a virus infecting cells is challenging what researchers have long believed about how viruses spread, suggesting that scientists may be able to create new drugs to tackle some viruses. Thu, 21 Jan 2010 14:11:11 EST http://www.sciencedaily.com/releases/2010/01/100121141102.htm http://www.sciencedaily.com/releases/2010/01/100120211025.htm A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2. Wed, 20 Jan 2010 21:10:10 EST http://www.sciencedaily.com/releases/2010/01/100120211025.htm http://www.sciencedaily.com/releases/2010/01/100108101431.htm Neuroscientists have forged an unlikely molecular union as part of their fight against diseases of the brain and nervous system, bringing together the herpes virus and a molecule known as Sleeping Beauty to improve gene therapy. The work has allowed scientists to reach a long-sought goal: shuttling into brain cells a relatively large gene that can remain on for an extended period of time. Fri, 08 Jan 2010 10:14:14 EST http://www.sciencedaily.com/releases/2010/01/100108101431.htm http://www.sciencedaily.com/releases/2009/12/091204092443.htm A new study found the chicken pox vaccine also reduces the risk of shingles among children. The study used electronic health records to identify and follow 172,000 vaccinated children for two-plus years and found that herpes zoster, known as shingles in adults, is very rare among children who have been vaccinated for chicken pox. This is the largest study of its kind. Fri, 04 Dec 2009 09:24:24 EST http://www.sciencedaily.com/releases/2009/12/091204092443.htm http://www.sciencedaily.com/releases/2009/11/091123212540.htm The decreased risk of HIV infection in circumcised men cannot be explained by a reduction in sores from conditions such as herpes, according to new research. Mon, 23 Nov 2009 21:25:25 EST http://www.sciencedaily.com/releases/2009/11/091123212540.htm http://www.sciencedaily.com/releases/2009/11/091109173712.htm Cumulative exposure to five common infection-causing pathogens may be associated with an increased risk of stroke, according to a new report. Mon, 09 Nov 2009 17:37:37 EST http://www.sciencedaily.com/releases/2009/11/091109173712.htm http://www.sciencedaily.com/releases/2009/10/091008161856.htm Adults who develop shingles are about 30 percent more likely to have a stroke within a year than adults who don't have shingles. When the shingles infection involves the skin around the eye and the eye itself, the risk of stroke may increase more than four-fold. Shingles is a painful skin rash caused by the same virus that causes chickenpox. Thu, 08 Oct 2009 16:18:18 EDT http://www.sciencedaily.com/releases/2009/10/091008161856.htm http://www.sciencedaily.com/releases/2009/10/091006191308.htm Drugs widely prescribed to treat facial paralysis in Bell's palsy are ineffective and are based on false notions of the cause of the condition, according to researchers. They say research must now focus on discovering other potential causes and treatments. Tue, 06 Oct 2009 19:13:13 EDT http://www.sciencedaily.com/releases/2009/10/091006191308.htm http://www.sciencedaily.com/releases/2009/09/090901163920.htm Among patients with Bell Palsy, a facial paralysis with unknown cause, treatment with corticosteroids is associated with a reduced risk of an unsatisfactory recovery, and treatment with a combination of corticosteroids and antiviral agents may be associated with additional benefit, according to a systematic review and meta-analysis of previously published studies. Tue, 01 Sep 2009 16:39:39 EDT http://www.sciencedaily.com/releases/2009/09/090901163920.htm http://www.sciencedaily.com/releases/2009/08/090802155237.htm New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Sun, 02 Aug 2009 15:52:52 EDT http://www.sciencedaily.com/releases/2009/08/090802155237.htm http://www.sciencedaily.com/releases/2009/07/090730092938.htm Researchers have identified a new potential drug target for the herpes virus that causes Kaposi's sarcoma, re-opening the possibility of using the class of drugs called protease inhibitors against the full herpes family of viruses, which for 20 years has been deemed too difficult to attain. Thu, 30 Jul 2009 09:29:29 EDT http://www.sciencedaily.com/releases/2009/07/090730092938.htm http://www.sciencedaily.com/releases/2009/07/090713170657.htm Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies. Mon, 13 Jul 2009 17:06:06 EDT http://www.sciencedaily.com/releases/2009/07/090713170657.htm http://www.sciencedaily.com/releases/2009/07/090701082702.htm The herpes simplex virus (HSV) can infect the eye and sometimes causes so much damage that the person's cornea must be replaced with a transplant. (The cornea is the clear covering of the front of the eye that helps focus light for vision.) Doctors knew transplants were more likely to fail in people with HSV than in patients with other disorders, such as keratoconus, an abnormal steepening of the cornea. Wed, 01 Jul 2009 08:27:27 EDT http://www.sciencedaily.com/releases/2009/07/090701082702.htm http://www.sciencedaily.com/releases/2009/06/090625100343.htm Eczema patients at risk for serious viral infections have more severe disease, are more likely to be allergic to food and other allergens, and have a frequent history of staph infections, according to researchers. The findings could help identify people at risk for serious complications of smallpox vaccinations, and point to defects in the skin barrier and antimicrobial-protein production as possible causes for the increased susceptibility. Thu, 25 Jun 2009 10:03:03 EDT http://www.sciencedaily.com/releases/2009/06/090625100343.htm http://www.sciencedaily.com/releases/2009/06/090611194127.htm Scientists have completed the first description of the mechanics of so-called nuclear herpes virus capsids. Thu, 11 Jun 2009 19:41:41 EDT http://www.sciencedaily.com/releases/2009/06/090611194127.htm http://www.sciencedaily.com/releases/2009/05/090508103831.htm Acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2, which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2. Fri, 08 May 2009 10:38:38 EDT http://www.sciencedaily.com/releases/2009/05/090508103831.htm http://www.sciencedaily.com/releases/2009/04/090407105159.htm Scientists have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections. This work identifies previously unrecognized first-line defense mechanisms that are particularly important in barrier locations such as the skin and the gut, often used as portals of entry by viruses and bacteria. Tue, 07 Apr 2009 10:51:51 EDT http://www.sciencedaily.com/releases/2009/04/090407105159.htm http://www.sciencedaily.com/releases/2009/03/090326215050.htm New research appears to solve a long standing medical mystery by identifying a viral protein, VP16, as the molecular key that prompts herpes simplex virus (HSV) to exit latency and cause recurrent disease. The new study points to a molecular target for designing improved HSV vaccines and treatments. Thu, 26 Mar 2009 21:50:50 EDT http://www.sciencedaily.com/releases/2009/03/090326215050.htm http://www.sciencedaily.com/releases/2009/03/090325180707.htm Researchers have determined that the herpes simplex virus type 1 (HSV-1) does not require transcriptional coactivators for viral gene expression early in the infection process. The finding is significant in determining that, in contradiction to earlier models, chemical inhibitors of these cellular proteins are not likely to serve as useful antiviral drugs. Wed, 25 Mar 2009 18:07:07 EDT http://www.sciencedaily.com/releases/2009/03/090325180707.htm http://www.sciencedaily.com/releases/2009/03/090325180705.htm Heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted infections -- herpes simplex virus type 2 (HSV-2), the cause of genital herpes, and human papillomavirus, which can cause cancer and genital warts, according to a new report. In the study, circumcision had no effect on their risk of becoming infected with the bacterium that causes syphilis. Wed, 25 Mar 2009 18:07:07 EDT http://www.sciencedaily.com/releases/2009/03/090325180705.htm